Standard Biotools Inc Financial Flexibility Index
Standard Biotools Inc financial flexibility index. Standard Biotools Inc (LAB) has a Financial Flexibility Index of -0.11x as of June 2026. Free cash flow of $-9.97 Million (operating CF $-10.31 Million minus capex $344.00K) represents 0% of total liabilities ($87.25 Million). See LAB cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Standard Biotools Inc (2006–2025)
Financial flexibility index of Standard Biotools Inc from 2006 to 2025. Historical Financial Flexibility Index trend for Standard Biotools Inc across 20 annual periods. Check how high is Standard Biotools Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Standard Biotools Inc Financial Flexibility Index by Year (2006–2025)
Standard Biotools Inc financial flexibility index by year from 2006 to 2025. Year-by-year free cash flow to debt coverage for Standard Biotools Inc. For the full cash flow conversion analysis, see LAB operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.46x | $-66.05 Million | $-74.35 Million | $143.46 Million | ▲ +52.1% |
| 2024 | -0.96x | $-135.10 Million | $-143.45 Million | $140.62 Million | ▼ -1018.8% |
| 2023 | -0.09x | $-40.46 Million | $-43.29 Million | $471.12 Million | ▲ +52.6% |
| 2022 | -0.18x | $-85.55 Million | $-89.37 Million | $471.78 Million | ▼ -6.3% |
| 2021 | -0.17x | $-30.80 Million | $-44.06 Million | $180.62 Million | ▼ -1072.8% |
| 2020 | -0.01x | $-2.70 Million | $-15.42 Million | $185.71 Million | ▲ +95.1% |
| 2019 | -0.29x | $-32.68 Million | $-35.21 Million | $111.20 Million | ▼ -174.0% |
| 2018 | -0.11x | $-24.83 Million | $-25.20 Million | $231.53 Million | ▼ -22.3% |
| 2017 | -0.09x | $-22.48 Million | $-24.10 Million | $256.42 Million | ▲ +34.8% |
| 2016 | -0.13x | $-34.03 Million | $-39.10 Million | $253.16 Million | ▼ -43.2% |
| 2015 | -0.09x | $-24.04 Million | $-34.70 Million | $256.16 Million | ▼ -58.6% |
| 2014 | -0.06x | $-15.22 Million | $-22.62 Million | $257.14 Million | ▼ -137.9% |
| 2013 | 0.16x | $3.10 Million | $-1.59 Million | $19.80 Million | ▲ +113.5% |
| 2012 | -1.15x | $-15.09 Million | $-17.48 Million | $13.07 Million | ▼ -63.2% |
| 2011 | -0.71x | $-15.87 Million | $-17.54 Million | $22.43 Million | ▼ -1418.3% |
| 2010 | -0.05x | $-9.97 Million | $-11.51 Million | $213.97 Million | ▲ +48.8% |
| 2009 | -0.09x | $-18.71 Million | $-19.51 Million | $205.77 Million | ▲ +37.6% |
| 2008 | -0.15x | $-27.81 Million | $-28.72 Million | $190.69 Million | ▼ -29.9% |
| 2007 | -0.11x | $-20.79 Million | $-21.76 Million | $185.11 Million | ▲ +17.3% |
| 2006 | -0.14x | $-19.37 Million | $-22.31 Million | $142.66 Million | — |